Implantable Cardioverter Defibrillators Show No Mortality Benefit in Certain Heart Attack Patients
New research at ESC 2025 suggests that implantable cardioverter defibrillators may not reduce mortality in certain post-heart attack patients with moderate LV dysfunction and arrhythmia risk markers.
Recent research presented at ESC Congress 2025 has questioned the effectiveness of implantable cardioverter defibrillators (ICDs) in reducing mortality among specific heart attack survivors. The study focused on patients with a history of myocardial infarction (MI), who also exhibited persistent moderate left ventricular (LV) systolic dysfunction and abnormal ECG markers indicative of increased arrhythmia risk.
The large, international REFINE-ICD trial involved nearly 2,000 post-MI patients across North America, Europe, the Middle East, and Africa. Participants underwent ambulatory ECG testing, assessing indicators like heart rate turbulence and T wave alternans, which are known to predict ventricular arrhythmias. Out of these, 597 patients with LVEF between 36-50%, impaired heart rate turbulence, and abnormal T wave alternans were randomized to receive a defibrillator along with optimal medical therapy or medical therapy alone.
The median age was 65 years, with 19% women. Overall, patients with both abnormal markers faced a higher risk of death. However, over an average follow-up of about 5.7 years, the study found no significant reduction in mortality due to ICD implantation. Deaths occurred at similar rates in both groups—24.5% in those with ICDs and 21.3% in the control group. Notably, nearly half of all deaths were non-cardiac, highlighting other factors influencing prognosis. Cardiac deaths and sudden cardiac death rates did not differ significantly between groups, indicating that the ICD did not provide a survival advantage for this patient subset.
Professor Derek Exner, lead investigator, summarized the findings, emphasizing that patients with prior MI, moderate LV dysfunction, and arrhythmia risk markers had a doubled risk of death compared to those without these risks. Yet, despite the higher risk profile, ICD therapy did not lead to a reduction in mortality or sudden cardiac death, suggesting a need to rethink intervention strategies for these patients. Further research is crucial to identify more effective methods for improving long-term outcomes in this high-risk group.
This study adds valuable insight into the ongoing evaluation of ICD utility beyond traditional indications and underscores the importance of personalized approaches to post-MI treatment.
Source: https://medicalxpress.com/news/2025-09-implantable-cardioverter-defibrillators-mortality-heart.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Arkansas Egg Producer Recalls Free-Range Brown Eggs Due to Salmonella Risk
Black Sheep Egg Company of Arkansas is recalling free-range brown eggs due to salmonella contamination detected during FDA inspections. Consumers are advised to discard affected eggs with specific best-by dates and UPC codes to prevent illness.
Proposed Expansion of Beta-Blocker Use to All Heart Attack Patients Regardless of Damage Level
New research supports prescribing beta-blockers to all heart attack patients, including those with minimal or no heart damage, to reduce future cardiac risks and improve outcomes. These findings could lead to updated treatment guidelines globally.
FDA Approves Effective Topical Foam for Treating Scalp and Body Plaque Psoriasis
The FDA has approved Zoryve foam, a steroid-free topical treatment for scalp and body plaque psoriasis in adolescents and adults, backed by clinical trial success in clearing psoriasis and relieving itching.
Study Finds Many Children Not Meeting Recommended Sleep Durations
A new study reveals that most children are not meeting recommended sleep durations, with parents often underestimating their kids' wakefulness during the night. Cultural factors and parental perceptions play a significant role in sleep health disparities among children.